 long-term observ intraves metaphylaxi mitomycin patient superfici bladder tumor transurethr resect superfici bladder tumor patient chemoprophylaxi mitomycin period year percent recurr diseas metaphylaxi patient recurrence-fre instil therapi averag month period percent patient recurr forty-four month instil major patient recurr tumor recurr tumor instil therapi patient percent recurrence-fre observ period twelv fifty-four month instil therapi conclus averag observ period month percent patient studi recurr